Effects of a novel cardioprotective drug, JTV-519, on membrane currents of guinea pig ventricular myocytes - PubMed (original) (raw)
Comparative Study
doi: 10.1254/jjp.79.275.
Affiliations
- PMID: 10230854
- DOI: 10.1254/jjp.79.275
Free article
Comparative Study
Effects of a novel cardioprotective drug, JTV-519, on membrane currents of guinea pig ventricular myocytes
J Kimura et al. Jpn J Pharmacol. 1999 Mar.
Free article
Abstract
We investigated effects of a novel cardioprotective drug, JTV-519 (4-[3-(4-benzylpiperidin-1-yl)propionyl]-7-methoxy-2,3,4,5-tetrahy dro-1,4-benzothiazepine monohydrochloride) on membrane currents of guinea pig ventricular myocytes by whole-cell voltage and current clamp methods. The fast Na+ current (iNa) was activated by ramp pulses from various holding potentials of -90, -80 or -60 mV to 10 mV with various intervals. At 0.2 Hz, JTV-519 inhibited iNa in a concentration-dependent manner with an IC50 of approximately 1.2 and 2 microM at the holding potential of -60 and -90 mM, respectively, implicating a voltage-dependent block. Increasing the pulse frequency from 1 to 2 or 3.3 Hz in the presence of 1 microM JTV-519 shortened the time-course and increased the level of iNa block, indicating a frequency-dependent block. The time-course of iNa blocking by JTV-519 was slower than that of lidocaine and similar to that of quinidine. Ca2+ current (iCa) and the inwardly rectifying K+ current (iK1) were also inhibited by JTV-519. JTV-519 decreased the duration and the height of the plateau of the action potential. We conclude that JTV-519 has frequency- and voltage-dependent blocking effects on iNa as well as inhibition of iCa and iK1.
Similar articles
- Inhibitory effects of JTV-519, a novel cardioprotective drug, on potassium currents and experimental atrial fibrillation in guinea-pig hearts.
Nakaya H, Furusawa Y, Ogura T, Tamagawa M, Uemura H. Nakaya H, et al. Br J Pharmacol. 2000 Dec;131(7):1363-72. doi: 10.1038/sj.bjp.0703713. Br J Pharmacol. 2000. PMID: 11090108 Free PMC article. - Effects of JTV-519, a novel anti-ischaemic drug, on the delayed rectifier K+ current in guinea-pig ventricular myocytes.
Kiriyama K, Kiyosue T, Wang JC, Dohi K, Arita M. Kiriyama K, et al. Naunyn Schmiedebergs Arch Pharmacol. 2000 Jun;361(6):646-53. doi: 10.1007/s002100000230. Naunyn Schmiedebergs Arch Pharmacol. 2000. PMID: 10882040 - SD-3212, a new class I and IV antiarrhythmic drug: a potent inhibitor of the muscarinic acetylcholine-receptor-operated potassium current in guinea-pig atrial cells.
Hara Y, Nakaya H. Hara Y, et al. Br J Pharmacol. 1995 Nov;116(6):2750-6. doi: 10.1111/j.1476-5381.1995.tb17237.x. Br J Pharmacol. 1995. PMID: 8591000 Free PMC article. - [New evolvement of antiarrhythmic drugs].
Kanno M. Kanno M. Nihon Yakurigaku Zasshi. 1993 Sep;102(3):215-23. doi: 10.1254/fpj.102.215. Nihon Yakurigaku Zasshi. 1993. PMID: 8406233 Review. Japanese. - Preconditioning: we do not need more experiments, because our current knowledge already permits us to develop pharmacological agents.
Opie LH. Opie LH. Basic Res Cardiol. 1997;92 Suppl 2:46-7. doi: 10.1007/BF00797208. Basic Res Cardiol. 1997. PMID: 9457372 Review. No abstract available.
Cited by
- Calcium signaling phenomena in heart diseases: a perspective.
Chakraborti S, Das S, Kar P, Ghosh B, Samanta K, Kolley S, Ghosh S, Roy S, Chakraborti T. Chakraborti S, et al. Mol Cell Biochem. 2007 Apr;298(1-2):1-40. doi: 10.1007/s11010-006-9355-8. Epub 2006 Nov 21. Mol Cell Biochem. 2007. PMID: 17119849 Review. - 2APB- and JTV519(K201)-sensitive micro Ca2+ waves in arrhythmogenic Purkinje cells that survive in infarcted canine heart.
Boyden PA, Dun W, Barbhaiya C, Ter Keurs HE. Boyden PA, et al. Heart Rhythm. 2004 Jul;1(2):218-26. doi: 10.1016/j.hrthm.2004.03.068. Heart Rhythm. 2004. PMID: 15851156 Free PMC article. - Targeting cardiomyocyte Ca2+ homeostasis in heart failure.
Roe AT, Frisk M, Louch WE. Roe AT, et al. Curr Pharm Des. 2015;21(4):431-48. doi: 10.2174/138161282104141204124129. Curr Pharm Des. 2015. PMID: 25483944 Free PMC article. Review. - Effect of Calstabin1 depletion on calcium transients and energy utilization in muscle fibers and treatment opportunities with RyR1 stabilizers.
Breckner A, Ganz M, Marcellin D, Richter J, Gerwin N, Rausch M. Breckner A, et al. PLoS One. 2013 Nov 26;8(11):e81277. doi: 10.1371/journal.pone.0081277. eCollection 2013. PLoS One. 2013. PMID: 24303040 Free PMC article. - Ryanodine receptor patents.
Kushnir A, Marks AR. Kushnir A, et al. Recent Pat Biotechnol. 2012 Dec;6(3):157-66. doi: 10.2174/1872208311206030157. Recent Pat Biotechnol. 2012. PMID: 23092431 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous